Practice Management
A large-scale clinical trial conducted by the National Cancer Institute found that one dose of an HPV vaccine is just as protective against infection as the traditional 2-dose regimen. The randomized study, which enrolled more than 20,000 girls aged 12 to 16 years, compared the effectiveness of 1 and 2 does of the bivalent Cervarix (GlaxoSmithKline) vaccine and the 9-valent Gardasil 9 (Merck) vaccine. Participants were assigned to receive either dosing regimen, and both groups …
Read More
In practice, just under half of pediatricians (49.5%) follow national recommendations from the American Academy of Pediatrics (AAP) for use of the antiviral oseltamivir for children hospitalized with influenza, according to survey results published in Pediatrics. The survey polled 787 physicians from 5 specialties among 7 children’s hospitals in the United States from March 2024 to June 2024. AAP recommends that all children hospitalized for flu receive oseltamivir. Knowing about AAP recommendations increased the pediatricians’ …
Read More
A review published last week in Health and Technology found that AI can read and interpret images more effectively and faster than radiologists, suggesting that AI could help make impact on today’s radiologist shortage. Even so, the industry must be mindful of the ethical and legal implications of AI use. To be clear, the authors state that AI can’t replace human radiologists but rather that AI tools can complement their work, offer guidance, and assist …
Read More
A multi-state study analyzed prescribing patterns of influenza antiviral medications in emergency departments (ED) and urgent care (UC) centers and found that many high-risk adults (those with cardiovascular disease, renal disease, weakened immune systems, or individuals older than 70 years) with positive influenza virus test results do not receive antiviral treatment, which the authors believe could help reduce the risk of complications. As published in Clinical Infectious Diseases, researchers found that slightly more than half …
Read More
Over the past few weeks, glucagon-like peptide-1 agonist (GLP-1) drug manufacturers Eli Lilly and Novo Nordisk have been sending cease and desist notices to providers that are still advertising generic, compounded versions of their brand name diabetes and weight loss drugs. A shortage of GLP-1 drugs temporarily allowed compounding pharmacies to produce their own versions, but now with the shortage over, the pharmacies must stop and return to filling prescriptions with the manufacturers’ branded products. …
Read More
The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota has established the Vaccine Integrity Project to offer vaccine recommendations and to review safety and effectiveness data, according to a press release. The project is guided by public health and policy experts—some of which served in previous positions at the Food and Drug Administration and the National Academy of Medicine—who will offer strategies to leverage scientific evidence for vaccine-related practices. To …
Read More
In the midst of ongoing retail pharmacy store closures, Amazon is pushing ahead on same-day home delivery of prescription medications, aiming to have delivery within reach of about half the U.S. market by the end of the year, according to MedPage Today. The offering seems like a natural complement to Amazon’s growing list of partners delivering telehealth visits and subscription-based digital health services. Walmart launched same-day deliveries less than a year ago and now reaches …
Read More
The protection offered by the respiratory syncytial virus (RSV) vaccine wanes over time for older adults, even with a booster dose 1 year after initial vaccination, according to a study published in Lancet Respiratory Medicine. This clinical trial of nearly 25,000 participants in 17 countries is one of the first studies measuring the efficacy of the relatively new RSV vaccine over subsequent seasons for those aged 60 years or older. Research data shows that efficacy …
Read More
In Mississippi, the House of Representatives passed a bill in February that would have allowed advanced practice nurses (APRNs) to treat patients without a collaboration agreement with a physician after accruing 8,000 hours of experience. However, the bill and another similar bill ultimately didn’t reach a vote before the legislative session ended earlier this month. The American Medical Association and the Mississippi State Medical Association lobbied against this expansion in scope of practice for APRNs …
Read More
The Centers for Disease Control and Prevention’s vaccine advisory committee voted on recommendations for 3 vaccines in recent days, according to CIDRAP. The committee recommended the use of the newly approved 5-in-1 meningococcal (groups A, B, C, W, and Y) vaccine as part of the adolescent meningococcal vaccination schedule. They also recommended that adults aged 50 to 59 years who are at increased risk of severe disease from respiratory syncytial virus (RSV) receive a single …
Read More